The omega-3 index as a risk factor for coronary heart disease.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic proposal without original data or systematic review methodology.
PubMed 18541601 · doi:10.1093/ajcn/87.6.1997S
What was done
This paper is a narrative review and proposal evaluating the omega-3 index (erythrocyte eicosapentaenoic acid [EPA] plus docosahexaenoic acid [DHA]) as a potential risk factor for coronary heart disease mortality, especially sudden cardiac death. The author reviewed biological mechanisms and epidemiological criteria for validating the index as a modifiable biomarker of dietary intake and cardiovascular risk.
What was found
The abstract reports no empirical data, sample sizes, effect estimates, or statistical analyses. It outlines proposed clinical risk categories for erythrocyte membrane omega-3 percentage: - High risk: <4% - Intermediate risk: 4-8% - Low risk: >8% Biochemical mechanisms described include alteration of membrane physical properties, modulation of membrane-bound proteins and ion channels, production of bioactive eicosanoids, and transcription factor regulation affecting gene expression.
Why it matters
The paper defines cutpoints for using red blood cell EPA and DHA concentrations as an established biomarker for cardiac risk stratification.
Limits
The publication is an expert narrative proposal with no new human data, randomized trials, or systematic search methodology presented in the abstract. Clinical utility is explicitly constrained by the current lack of standardized laboratory assay methods and quality control reference materials.
Cited by
- supports People with an omega-3 index of 8% or higher had a 90% lower risk of sudden cardiac death compared to those with an index of 4% or below.